Answers are grounded in this paper and cite their sources.
Background: Intractable pruritus is a major factor reducing quality of life in patients with cutaneous T-cell lymphoma (CTCL). Traditional antipruritic medication shows little to no efficacy, partly due to a lack of knowledge about the underlying mechanism. We investigate the transcriptional signature of the cutaneous microenvironment (CME) and in particular the keratinocytes to identify potential targets driving pruritus in CTCL. Methods: Spatial and single-cell transcriptomic profiling was performed on pruritic and non-pruritic human CTCL skin samples. Formalin-fixed paraffin embedded (FFPE) skin samples from patients with (n=3) and without (n=3) pruritus have been selected. For spatial transcriptomic analysis, immunofluorescent staining of keratinocytes (E-cadherin), subepidermal immune cells (CD45) and fibroblasts (Vimentin) (Figure1A) was used to determine respective regions of interests (ROIs) (n=96) and quantify >18'000 genes. In a second cohort of CTCL skin samples with and without pruritus (2x n=5), multimodal single-cell sequencing has been performed to investigate transcriptome, surface proteome and T-cell receptor hyperexpansion. Results: Spatial transcriptional profiling of key cell types within the CME revealed a pruritus-specific signature of epidermal keratinocytes. Gene set enrichment analysis confirmed enhanced sensory function (p<0.001) (Figure1B) in pruritic keratinocyte subpopulation. Within the immune compartment, pruritic and non-pruritic skin had a divergent cell-type composition (p=0.01) (Figure1C), driven by a significantly increased fraction of CD4 memory cells in pruritic CTCL skin (p<0.01) (Figure1D). Additional single-cell profiling identified a distinct keratinocyte cluster expressing sensory receptors known for interleukin-mediated signaling (e.g. OSMR, IL4R). Further, malignant and non-malignant CD4 T-cells differed in the expression pattern of cytokines and interleukins (e.g. IL4). Intercellular communication networks within the CME highlighted interleukin- mediated signaling between immune-cells and specific keratinocyte populations as major interaction paths (e.g. IL4/IL4R). Potential druggable receptor targets were primarily expressed in the CME, but not by T-cells. Figure 1 (A) Immunofluorescent staining for selection of ROIs (B) Top upregulated pathways in pruritic versus non-pruritic keratinocytes. (C) Cellular composition of immune segment. (D) Fractional upregulation of CD4 memory T-cells in pruritic CD45 compartment. Conclusions: Our results highlight the contribution of the keratinocyte-immune crosstalk to pruritic sensation and the sensory function of keratinocytes. Different expression patterns of sensory receptors within the CME could guide safe repurposing of targeted antipruritic medications.
No takes yet. Share an insight, caveat, or question.
Roggo et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: